missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CXCL1/2/3/GRO Pan Specific Antibody, R&D Systems™

Mouse Monoclonal Antibody
Brand: R&D Systems MAB2761-SP
This item is not returnable.
View return policy
Description
CXCL1/2/3/GRO Monoclonal specifically detects CXCL1/2/3/GRO in Human samples. It is validated for Western Blot, Intracellular Staining by Flow Cytometry, CyTOF-ready.
Specifications
| CXCL1/2/3/GRO | |
| Monoclonal | |
| LYOPH | |
| Western Blot 1 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
| P19876 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 2919 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
| Western Blot, Flow Cytometry, CyTOF | |
| 29702 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CINC1, CINC-1, CINC-2, CINC3, CINC-3, Dcip1, FSP, Gm1960, GRO alpha, GRO beta, GRO gamma, GRO1, GROa, KC, MGSA, MGSA-a, MGSA-alpha, MGSA-beta, MIP-2, NAP-3, SCYB1 | |
| E. coli-derived recombinant human CXCL3 Ala35-Asn107 Accession # P19876 | |
| 25 μg | |
| Primary | |
| Detects human CXCL1/2/3 in direct ELISAs and Western blots. In direct ELISAs, 100% cross-reactivity with recombinant mouse (rm) CXCL2 is observed and no cross-reactivity with recombinant human (rh) VIC, rmVIC, rhCCL3L1, rhCCL4L1, or recombinant canine IL-8 is observed. | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction